Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Skin reactions from cancer treatments might predict how well the treatments work.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Green tea may help with skin health and protect against UV damage, but more research is needed to confirm its safety and effectiveness.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.